Explore
Validate
LearnARP45817_T100
antibody from Aviva Systems Biology
Targeting: GATD3A
C21orf33, D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ARP45817_T100 - Provider product page
- Provider
- Aviva Systems Biology
- Proper citation
- Aviva Systems Biology Cat#ARP45817_T100, RRID:AB_1294062
- Product name
- C21orf33 antibody - N-terminal region (ARP45817_T100)
- Antibody type
- Polyclonal
- Antigen
- The immunogen is a synthetic peptide directed towards the N terminal region of human C21orf33
- Description
- Protein A purified
- Reactivity
- Human, Mouse, Rat, Bovine, Guinea Pig, Horse, Sheep, Zebrafish
- Host
- Rabbit
- Vial size
- 100 μl
- Concentration
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- Storage
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- WB SuggestedAntibody Titration: 2.5µg/ml. Positive Control: HepG2C21orf33 is supported by BioGPS gene expression data to be expressed in HepG2
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Immunohistochemistry staining of Human Muscle with Anti-C21orf33 antibody
- Sample type
- Human Muscle
- Validation comment
- This location is supported by literature
- Primary Ab dilution
- 4.0-8.8888
- Secondary Ab
- Secondary Ab
- Secondary Ab dilution
- 0.5ug/mL 0.2ug/mL
- Protocol
- Protocol
